Search

Search Constraints

You searched for: Author/Creator Oehme, Ina

Search Results

1. A kinome-wide RNAi screen identifies ALK as a target to sensitize neuroblastoma cells for HDAC8-inhibitor treatment. Issue 12 (December 2018)

2. BH3 mimetics targeting BCL-XL impact the senescent compartment of pilocytic astrocytoma. Issue 4 (17th August 2022)

3. DDEL-01. The role of key pharmacodynamic and pharmacokinetic parameters in drug response prediction of pediatric tumors in the precision oncology study INFORM. (3rd June 2022)

4. Design and Synthesis of Dihydroxamic Acids as HDAC6/8/10 Inhibitors. (13th May 2020)

5. EMBR-01. CLASS I HDAC INHIBITORS AND PLK1 INHIBITORS SYNERGIZE IN MYC-AMPLIFIED MEDULLOBLASTOMA. (1st June 2021)

7. ERBB and P‐glycoprotein inhibitors break resistance in relapsed neuroblastoma models through P‐glycoprotein. Issue 1 (5th November 2022)

8. First Fluorescent Acetylspermidine Deacetylation Assay for HDAC10 Identifies Selective Inhibitors with Cellular Target Engagement. (10th June 2022)

9. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Issue 1 (2nd January 2016)

10. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1. Issue 1 (2nd January 2021)